| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5900177 | Diabetes Research and Clinical Practice | 2012 | 7 Pages |
Abstract
Severe hypoglycaemia is more frequent in patients with type 1 diabetes treated with long-acting insulin analogues. Confounding by indication may be involved. Clinical intervention trials using insulin analogues in patients prone to severe hypoglycaemia are highly needed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
P.L. Kristensen, L.S. Hansen, M.J. Jespersen, U. Pedersen-Bjergaard, H. Beck-Nielsen, J.S. Christiansen, K. Nørgaard, H. Perrild, H.-H. Parving, B. Thorsteinsson, L. Tarnow,